8 recruiting, 1 not yet recruiting. 8 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Recruiting 7, Not yet recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow HC Biopharma Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Double-Blind, Positive-Controlled, Parallel Pharmacokinetic Phase I Clinical Study of Cetuximab Injection Versus Erbitux in Healthy Male Subjects HC034S, Erbitux (Cetuximab) - Cetuximab, Bioequivalence | Phase 1 | Recruiting | HC Biopharma Inc. | 92 | 2026-09-05 | 2026-09-10 |
| A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combinations in Advanced Solid Tumors HC010, Paclitaxel, Oxaliplatin - Advanced Solid Tumor Cancer | Phase 1 | Recruiting | HC Biopharma Inc. | 331 | 2026-03-17 | 2026-03-17 |
| The Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HC022 Injection in Subjects With SLE/CLE HC022, Placebo - Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE) | Phase 1 | Not yet recruiting | HC Biopharma Inc. | 32 | 2025-12-30 | 2026-01-28 |
| HC010 in First-line PD-L1 Positive Advanced NSCLC Patients HC010 - NSCLC | Phase 2 | Recruiting | HC Biopharma Inc. | 50 | 2025-12-09 | 2025-12-17 |
| A Phase Ib Clinical Study on the Safety and Efficacy of HC010 Combined With Chemotherapy in Lung Cancer HC010, Paclitaxel (Chemotherapy), Pemetrexed - Advanced Solid Tumor Cancer | Phase 1 | Recruiting | HC Biopharma Inc. | 328 | 2025-10-27 | 2026-02-02 |
| Study of HC006 in Combination With a PD-1 Inhibitor in Patients With Advanced Solid Tumors HC006, KEYTRUDA ®( Pembrolizumab) - Advanced Cancer | Phase 1 | Recruiting | HC Biopharma Inc. | 252 | 2025-07-04 | 2025-07-17 |
| Safety, Tolerability, and Pharmacokinetics of Single Doses of HC022 in Healthy Subjects. HC022, Placebo - Systemic Lupus Erythematosus | Phase 1 | Recruiting | HC Biopharma Inc. | 38 | 2024-11-25 | 2025-04-17 |
| A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors HC010 - Advanced Solid Tumor | Phase 1 | Recruiting | HC Biopharma Inc. | 122 | 2024-03-27 | 2025-05-13 |
| A Study of HC006 in Subjects With Advanced Solid Tumors HC006 - Advanced Solid Tumor | Phase 1 | Recruiting | HC Biopharma Inc. | 76 | 2024-02-27 | 2025-05-06 |
Lupus Erythematosus, Systemic (2) · Carcinoma, Hepatocellular (1) · Carcinoma, Non-Small-Cell Lung (1) · Colorectal Neoplasms (1) · Lupus Erythematosus, Cutaneous (1) · Uterine Cervical Neoplasms (1)
Paclitaxel (2) · Capecitabine (1) · Carboplatin (1) · Cetuximab (1) · Cisplatin (1) · Docetaxel (1) · Drug Therapy (1) · Etoposide (1) · Oxaliplatin (1) · Pemetrexed (1)
China (9)